Cargando…
Biomarkers and Preclinical Models for Adult T-Cell Leukemia-Lymphoma Treatment
Adult T-cell leukemia/lymphoma (ATL) is an aggressive lymphoproliferative malignancy with a very poor prognosis. Despite several recent advances, new therapeutic approaches are critical, and this will require successful preclinical studies, including studies in ATL cell culture systems, and mouse mo...
Autor principal: | Ratner, Lee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759749/ https://www.ncbi.nlm.nih.gov/pubmed/31620102 http://dx.doi.org/10.3389/fmicb.2019.02109 |
Ejemplares similares
-
Novel Treatments of Adult T Cell Leukemia Lymphoma
por: El Hajj, Hiba, et al.
Publicado: (2020) -
Diagnostic Approaches and Established Treatments for Adult T Cell Leukemia Lymphoma
por: Tsukasaki, Kunihiro, et al.
Publicado: (2020) -
Future Perspectives on Drug Targeting in Adult T Cell Leukemia-Lymphoma
por: Marino-Merlo, Francesca, et al.
Publicado: (2018) -
Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma
por: Utsunomiya, Atae
Publicado: (2019) -
HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia–Lymphoma
por: Yamagishi, Makoto, et al.
Publicado: (2018)